Mid-term report 2016 – Cancer prevention and precision medicine

In connection with Stiftelsen Kristian Gerhard Jebsen's Mid-term evaluation of The K.G. Jebsen Colorectal Cancer Research Centre, we have issued a Mid-term report.

Mid-term report 2016

Link to the report Mid-term_report 2016_oppslag

Latest publications

Smeby et al. 2020. Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity. EBioMedicine 59: 102923 Eilertsen et al. 2020. Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer. Cancer Lett. 469: 246-255 Araghi et al. 2020. Colon and rectal cancer survival in seven high-income countries 2010–2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project). Gut gutjnl-2020-320625 Lopes et al. 2020. A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis. Gastric Cancer 23: 811-823 Bruun et al. 2020. Patient-derived organoids from multiple colorectal cancer liver metastases reveal moderate intra-patient pharmacotranscriptomic heterogeneity. Clin. Cancer Res. 26: 4107-4119 All publications